Protara Therapeutics Inc (TARA)
2.91
0.00 (0.00%)
USD |
NASDAQ |
May 06, 16:00
2.91
0.00 (0.00%)
After-Hours: 17:53
Protara Therapeutics Net Income (TTM): -40.42M for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -40.42M |
| September 30, 2023 | -69.17M |
| June 30, 2023 | -67.00M |
| March 31, 2023 | -64.24M |
| December 31, 2022 | -65.95M |
| September 30, 2022 | -37.21M |
| June 30, 2022 | -40.30M |
| March 31, 2022 | -44.54M |
| Date | Value |
|---|---|
| December 31, 2021 | -47.25M |
| September 30, 2021 | -45.83M |
| June 30, 2021 | -43.02M |
| March 31, 2021 | -37.38M |
| December 31, 2020 | -33.98M |
| September 30, 2020 | -27.69M |
| June 30, 2020 | -22.07M |
| March 31, 2020 | -16.36M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-69.17M
Minimum
Sep 2023
-16.36M
Maximum
Mar 2020
-43.90M
Average
-41.72M
Median
Net Income (TTM) Benchmarks
| AngioDynamics Inc | -192.37M |
| Regulus Therapeutics Inc | -30.04M |
| Bio-Path Holdings Inc | -16.08M |
| Outset Medical Inc | -172.80M |
| AN2 Therapeutics Inc | -64.73M |